MARY KELLEY: Open Payments
NPI 1720646862 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 24 payments from 10 companies in 2025. Trend: 2023 $279 · 2024 $545 · 2025 $996
Food & beverage: $511Consulting: $394Education: $91
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $636 |
| Teva Pharmaceuticals USA, Inc. | 1 | $91 |
| ARGENX US, INC. | 2 | $90 |
| Janssen Biotech, Inc. | 1 | $50 |
| UCB, Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: BOTOX, UBRELVY, QULIPTA, VYVGART, Rystiggo, General - DBS, WAINUA, CAMZYOS.
Industry payments across OR — which companies pay providers there.
